No one has really talked much about Paul Field, PharmAust Business Development Advisor.
The caption below is from the PharmAust website.
Paul's role is to assist PharmAust with it's partnering campaign for Monepantel.
An incredible comment really - we have hired Paul, with a wealth of experience, to assist with finding partners. Paul has been with us since April.
I notice Paul was on the investment committee for the Horizon 3 Healthcare fund which deployed $80M ... including getting in early on Neuren Pharmaceuticals.
No one has really talked much about Paul Field, PharmAust...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.3¢ |
Change
0.008(4.05%) |
Mkt cap ! $91.16M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.5¢ | $172.3K | 913.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 61068 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 521930 | 5 |
View Market Depth
| Last trade - 11.05am 02/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |